Cargando…
CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
Chimeric antigen receptor T cells (CAR T cells) are effective against haematologic malignancies. However, in solid tumours, their potency is hampered by local immunosuppression and by the heterogeneous expression of the antigen that the CAR targets. Here we show that CAR T cells expressing a pluripo...
Autores principales: | Jin, Chuan, Ma, Jing, Ramachandran, Mohanraj, Yu, Di, Essand, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288934/ https://www.ncbi.nlm.nih.gov/pubmed/35379957 http://dx.doi.org/10.1038/s41551-022-00875-5 |
Ejemplares similares
-
Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer
por: Jin, Chuan, et al.
Publicado: (2016) -
Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
por: Hillerdal, Victoria, et al.
Publicado: (2014) -
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
por: Fu, Wenyan, et al.
Publicado: (2019) -
Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
por: Ma, Jing, et al.
Publicado: (2020) -
An Infection-enhanced Oncolytic Adenovirus Secreting H. pylori Neutrophil-activating Protein with Therapeutic Effects on Neuroendocrine Tumors
por: Ramachandran, Mohanraj, et al.
Publicado: (2013)